Cargando…

Correction: Intrinsic adriamycin resistance in p53-mutated breast cancer is related to the miR-30c/FANCF/REV1-mediated DNA damage response

Detalles Bibliográficos
Autores principales:	Lin, Shu, Yu, Lifeng, Song, Xinyue, Bi, Jia, Jiang, Longyang, Wang, Yan, He, Miao, Xiao, Qinghuan, Sun, Mingli, Olopade, Olufunmilayo I., Zhao, Lin, Wei, Minjie
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2022
Materias:	Correction
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8789896/ https://www.ncbi.nlm.nih.gov/pubmed/35078992 http://dx.doi.org/10.1038/s41419-022-04543-z

Ejemplares similares

Intrinsic adriamycin resistance in p53-mutated breast cancer is related to the miR-30c/FANCF/REV1-mediated DNA damage response
por: Lin, Shu, et al.
Publicado: (2019)

RNA interference-mediated FANCF silencing sensitizes OVCAR3 ovarian cancer cells to adriamycin through increased adriamycin-induced apoptosis dependent on JNK activation
por: HE, MIAO, et al.
Publicado: (2013)

RNA interference-mediated FANCF silencing sensitizes OVCAR3 ovarian cancer cells to adriamycin through increased adriamycin-induced apoptosis dependent on JNK activation
por: He, Miao, et al.
Publicado: (2022)

MiR-302a/b/c/d cooperatively sensitizes breast cancer cells to adriamycin via suppressing P-glycoprotein(P-gp) by targeting MAP/ERK kinase kinase 1 (MEKK1)
por: Zhao, Lin, et al.
Publicado: (2016)

Correction to: MiR-302a/b/c/d cooperatively sensitizes breast cancer cells to adriamycin via suppressing P-glycoprotein(P-gp) by targeting MAP/ERK kinase kinase 1 (MEKK1)
por: Zhao, Lin, et al.
Publicado: (2022)

Promoter hypermethylation of FANCF and outcome in advanced ovarian cancer
por: Lim, S L, et al.
Publicado: (2008)

Gene Silencing of FANCF Potentiates the Sensitivity to Mitoxantrone through Activation of JNK and p38 Signal Pathways in Breast Cancer Cells
por: Li, Yanlin, et al.
Publicado: (2012)

No Evidence for FANCF Gene Silencing in Head-and-Neck Squamous Cell Carcinomas
por: Ameziane, Najim, et al.
Publicado: (2009)

The FANCC–FANCE–FANCF complex is evolutionarily conserved and regulates meiotic recombination
por: Singh, Dipesh Kumar, et al.
Publicado: (2023)

The First Case of Acute Myeloid Leukemia With Underlying Fanconi Anemia due to FANCF Variants in Korea
por: Suh, Eunsang, et al.
Publicado: (2023)

Adriamycin does not damage podocytes of zebrafish larvae
por: Schindler, Maximilian, et al.
Publicado: (2020)

Clinical importance of FANCD2, BRIP1, BRCA1, BRCA2 and FANCF expression in ovarian carcinomas
por: Moes-Sosnowska, Joanna, et al.
Publicado: (2019)

– (-) Menthol Induces Reversal of Promoter Hypermethylation and Associated Up-Regulation of the FANCF Gene in the SiHa Cell Line
por: Parashar, Gaurav, et al.
Publicado: (2017)

HIF-2α promotes conversion to a stem cell phenotype and induces chemoresistance in breast cancer cells by activating Wnt and Notch pathways
por: Yan, Yuanyuan, et al.
Publicado: (2018)

Comments by Delegations of Member States concerning Documents CERN/SPC/18/Rev.2, CERN/SPC/25/Rev.2, CERN/SPC/30/Rev.2
Publicado: (1956)

RNAi-mediated knockdown of FANCF suppresses cell proliferation, migration, invasion, and drug resistance potential of breast cancer cells
por: Zhao, L., et al.
Publicado: (2013)

A novel frame-shift deletion in FANCF gene causing autosomal recessive Fanconi anemia: a case report
por: Zareifar, Soheila, et al.
Publicado: (2019)

Further Comments by Delegations of Member States concerning Documents CERN/SPC/18/Rev.2, CERN/SPC/25/Rev.2, CERN/SPC/30/Rev.2
Publicado: (1956)

Adriamycin/cyclophosphamide and adriamycin/melphalan in advanced L1210 leukaemia.
por: Tobias, J. S., et al.
Publicado: (1975)

Overexpression of PTPRN Promotes Metastasis of Lung Adenocarcinoma and Suppresses NK Cell Cytotoxicity
por: Song, Xinyue, et al.
Publicado: (2021)

Ano1/TMEM16A Overexpression Is Associated with Good Prognosis in PR-Positive or HER2-Negative Breast Cancer Patients following Tamoxifen Treatment
por: Wu, Huizhe, et al.
Publicado: (2015)

Glomerular Endothelial Cell Injury and Damage Precedes That of Podocytes in Adriamycin-Induced Nephropathy
por: Sun, Yu Bo Yang, et al.
Publicado: (2013)

Inhibitors of adriamycin-induced histamine release in vitro limit adriamycin cardiotoxicity in vivo.
por: Klugmann, F. B., et al.
Publicado: (1986)

REV7 is essential for DNA damage tolerance via two REV3L binding sites in mammalian DNA polymerase ζ
por: Tomida, Junya, et al.
Publicado: (2015)

Detection of Adriamycin–DNA adducts by accelerator mass spectrometry at clinically relevant Adriamycin concentrations
por: Coldwell, Kate E., et al.
Publicado: (2008)

LncRNA CBR3-AS1 regulates of breast cancer drug sensitivity as a competing endogenous RNA through the JNK1/MEK4-mediated MAPK signal pathway
por: Zhang, Ming, et al.
Publicado: (2021)

Glycolysis gene expression profilings screen for prognostic risk signature of hepatocellular carcinoma
por: Jiang, Longyang, et al.
Publicado: (2019)

Genetic and physical interactions between Polη and Rev1 in response to UV-induced DNA damage in mammalian cells
por: Bi, Tonghui, et al.
Publicado: (2021)

RNA-directed remodeling of the HIV-1 protein Rev orchestrates assembly of the Rev–Rev response element complex
por: Jayaraman, Bhargavi, et al.
Publicado: (2014)

CpG methylation of the FHIT, FANCF, cyclin-D2, BRCA2 and RUNX3 genes in Granulosa cell tumors (GCTs) of ovarian origin
por: Dhillon, Varinderpal S, et al.
Publicado: (2004)

Endothelin Receptor A Blockade Is an Ineffective Treatment for Adriamycin Nephropathy
por: Tan, Roderick J., et al.
Publicado: (2013)

Doing better and being better in breast cancer care: an interview with Funmi Olopade
por: Olopade, Olufunmilayo I.
Publicado: (2021)

Identification of DNA-Repair-Related Five-Gene Signature to Predict Prognosis in Patients with Esophageal Cancer
por: Wang, Lin, et al.
Publicado: (2021)

LEAR lattices for Pb runs with longitudinal and transverse multiturn injection (Rev. 30 Nov. 1994)
por: Giannini, R
Publicado: (1996)

Adriamycin-resistant cells are significantly less fit than adriamycin-sensitive cells in cervical cancer
por: Qi, Min, et al.
Publicado: (2021)

Naringenin suppresses K562 human leukemia cell proliferation and ameliorates Adriamycin-induced oxidative damage in polymorphonuclear leukocytes
por: LI, RUI-FANG, et al.
Publicado: (2015)

Mad2B forms a complex with Cdc20, Cdc27, Rev3 and Rev1 in response to cisplatin-induced DNA damage
por: Kim, Ju Hwan, et al.
Publicado: (2023)

Protection Effect of Zhen-Wu-Tang on Adriamycin-Induced Nephrotic Syndrome via Inhibiting Oxidative Lesions and Inflammation Damage
por: Liang, Chun-ling, et al.
Publicado: (2014)

PARP inhibitor re-sensitizes Adriamycin resistant leukemia cells through DNA damage and apoptosis
por: Wu, Jie, et al.
Publicado: (2019)

Therapeutic Potential of Astragaloside IV Against Adriamycin-Induced Renal Damage in Rats via Ferroptosis
por: Qin, Lu-Yun, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_9h9vg4hk9kid2m5mt1vtp9pin4